Drug Discovery World
Now entering its 18th year, DDW stands out as the only truly global publication dedicated to all facets of drug discovery and development. It has earned a reputation as an essential journal within the industry, respected by professionals in the field. DDW is well-known for featuring insights from some of the top experts in the industry, providing a platform for these thought leaders to discuss and stimulate conversations around the pressing challenges related to the technological, strategic, and business aspects of the pharmaceutical and biopharmaceutical sectors. The journal operates on the principle of "Turning Science into Business." The publication explores the latest advancements in science and technology while focusing on their commercial implications. It aims to assess whether these innovations can genuinely enhance the drug discovery and development process, ultimately lowering costs and reducing failure rates, all while accelerating the introduction of new and effective therapies to the market. What sets DDW apart is its ability to engage a worldwide audience, from laboratory professionals to corporate leaders, helping them grasp new technologies and strategies and understand their potential impact on their specific areas of business.
Outlet metrics
Global
#1132983
United Kingdom
#214610
Science and Education/Biology
#425
Articles
-
5 days ago |
ddw-online.com | Megan Thomas
The UK National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending AstraZeneca’s Forxiga (dapagliflozin) as an option to treat chronic kidney disease (CKD) in adults in certain cases.
-
6 days ago |
ddw-online.com | Megan Thomas
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson’s.
-
6 days ago |
ddw-online.com | Diana Spencer
FUJIFILM Irvine Scientific, headquartered in Santa Ana, California is to rebrand as FUJIFILM Biosciences as part of a new structure and strategy for the group. FUJIFILM Corporation’s Life Sciences Group says the new names, collaborative strategic focus, and structural alignment reflects its commitment to life sciences.
-
6 days ago |
ddw-online.com | Diana Spencer
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. The webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development.
-
6 days ago |
ddw-online.com | Diana Spencer
On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite drug discovery.
Drug Discovery World journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://ddw-online.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →